STATE OF WISCONSIN INVESTMENT BOARD - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$2,573,686
+44.8%
97,599
-5.6%
0.01%
+60.0%
Q2 2023$1,777,551
+72.8%
103,346
+66.5%
0.01%
+66.7%
Q1 2023$1,028,938
-1.5%
62,059
-54.7%
0.00%0.0%
Q4 2022$1,044,870
-25.6%
137,122
-2.9%
0.00%
-25.0%
Q3 2022$1,404,000
-6.5%
141,224
-14.6%
0.00%0.0%
Q2 2022$1,502,000
-25.3%
165,423
-16.5%
0.00%0.0%
Q1 2022$2,011,000
-16.4%
198,089
+37.4%
0.00%
-20.0%
Q4 2021$2,405,000
-63.1%
144,189
+3.6%
0.01%
-64.3%
Q3 2021$6,524,000
-23.1%
139,1890.0%0.01%
-22.2%
Q2 2021$8,485,000
+8.7%
139,189
+9.9%
0.02%
+5.9%
Q1 2021$7,804,000
+5.6%
126,689
+21.9%
0.02%0.0%
Q4 2020$7,388,000
+68.6%
103,900
-11.0%
0.02%
+54.5%
Q3 2020$4,382,000
+15.0%
116,8000.0%0.01%0.0%
Q2 2020$3,809,000
+13.5%
116,800
+1.0%
0.01%0.0%
Q1 2020$3,355,000
+179.1%
115,700
+237.3%
0.01%
+266.7%
Q4 2019$1,202,000
+63.3%
34,3000.0%0.00%
+50.0%
Q3 2019$736,00034,3000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders